Abstract
Background: Chemotherapy damage ovarian reserve and may lead to premature ovarian failure (POF). Ovarian tissue cryopreservation has been proposed as one of the alternatives to fertility preservation. Anti-mullerian hormone (AMH) testing has become a useful tool for assessing the iatrogenic damage to the ovarian reserve.
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
